ro.laurent
Submits third-party assay reports on material purchased directly. Based in Rennes.
Section 1
Contribution
Purchases material, pays for assays, and submits the resulting reports to the index.
Records submitted
9
n=9
Annotations
0
n=0
Median purity submitted
99.15%
n=9
Suppliers covered
7
n=9
Section 2
Records submitted
A submitter chose to buy this material and to pay for this assay. That choice is the selection mechanism behind the whole index and it is not random.
| Report | Compound | Supplier | Lot | Lab | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-042494 | SS-31 (Elamipretide) | Homopeptide | HOMO-2604-D5484 | Kestrel | 2026-Q3 | 99.93 | 2.69 | 96.0 | Buyer-sourced | 0 | PASS |
| AX-2026-042112 | Tirzepatide | JEEP | JEEP-2602-J7978 | Janoshik | 2026-Q2 | 99.15 | 4.37 | — | Buyer-sourced | 0 | PASS |
| AX-2026-043456 | GHRP-2 | BCH | BCH-2508-M4472 | VendorInvestigate | 2026-Q1 | 98.32 | 5.39 | 105.8 | Buyer-sourced | 0 | FAIL |
| AX-2026-041566 | Semaglutide | QSC | QSC-2602-G7336 | Janoshik | 2026-Q1 | 98.31 | 4.97 | — | Buyer-sourced | 0 | PASS |
| AX-2025-019537 | CJC-1295 (no DAC) | TFC | TFC-2507-C9225 | Kestrel | 2025-Q4 | 99.68 | 5.13 | 98.3 | Buyer-sourced | 0 | PASS |
| AX-2025-020757 | Semaglutide | SGN | SGN-2502-J9369 | Janoshik | 2025-Q2 | 98.12 | 5.43 | 96.6 | Buyer-sourced | 0 | PASS |
| AX-2025-018676 | Tirzepatide | QSC | QSC-2410-R5814 | Nordanalyt | 2025-Q1 | 99.20 | 5.31 | 99.5 | Buyer-sourced | 0 | PASS |
| AX-2025-021125 | Epitalon | SIG | SIG-2412-6325 | Janoshik | 2025-Q1 | 99.42 | 8.30 | 89.6 | Buyer-sourced | 1 | MARGINAL |
| AX-2024-005117 | Tirzepatide | SGN | SGN-2411-N9012 | Janoshik | 2024-Q4 | 99.06 | 3.22 | 101.4 | Buyer-sourced | 0 | PASS |